NY Methodist Expands Treatment Options for Liver Cancer
For patients with liver cancer, the spectrum of treatment options offered by New York Methodist Hospital (NYM) is broad. Continuing advances in technology and additions to NYM’s staff have enabled the Hospital to customize its approach to liver cancer treatment, ensuring that patients with malignant liver tumors have the best chance of beating the disease.
“If a patient has cancer in the liver and it has not spread to other parts of the body, then we know one thing: there is some way to remove that cancer entirely, and to limit the chance of a recurrence,” said Smruti Mohanty, M.D., chief of gastroenterology and hepatology at NYM. “However, the challenge is finding the best treatment, or combination of treatments, for that patient’s cancer. Whatever circumstances patients face, NYM offers treatments that can help them turn the tables on liver cancer.”
Although the majority of liver cancer tumors are inoperable, one in three patients with liver tumors are candidates for liver resection – the complete surgical removal of the tumor itself and the affected area immediately around it. Liver cancer resections are complicated surgeries; at NYM they are performed by Syed Shah, M.D., the hospital’s chief of hepatobiliary and pancreatic surgery. Board certified in surgery and critical care, Dr. Shah specializes in expertly performing some of the most demanding surgical procedures.